SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008566
Filing Date
2019-05-14
Accepted
2019-05-14 16:13:19
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_chinapharma.htm 10-Q 327810
2 CERTIFICATION f10q0319ex31-1_chinapharma.htm EX-31.1 13170
3 CERTIFICATION f10q0319ex31-2_chinapharma.htm EX-31.2 13079
4 CERTIFICATION f10q0319ex32-1_chinapharma.htm EX-32.1 6704
  Complete submission text file 0001213900-19-008566.txt   2287465

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20190331.xml EX-101.INS 307589
6 XBRL SCHEMA FILE cphi-20190331.xsd EX-101.SCH 34215
7 XBRL CALCULATION FILE cphi-20190331_cal.xml EX-101.CAL 60139
8 XBRL DEFINITION FILE cphi-20190331_def.xml EX-101.DEF 67895
9 XBRL LABEL FILE cphi-20190331_lab.xml EX-101.LAB 228525
10 XBRL PRESENTATION FILE cphi-20190331_pre.xml EX-101.PRE 171874
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 19822850
SIC: 2834 Pharmaceutical Preparations